87489535 - ESCALATE

Information

  • Trademark
  • 87489535
  • Serial Number
    87489535
  • Registration Number
    5462359
  • Filing Date
    June 14, 2017
    7 years ago
  • Registration Date
    May 08, 2018
    6 years ago
  • Transaction Date
    November 05, 2024
    2 months ago
  • Status Date
    October 03, 2024
    3 months ago
  • Published for Opposition Date
    February 20, 2018
    6 years ago
  • Location Date
    October 03, 2024
    3 months ago
  • Status Code
    705
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LAVOIE, RYAN
  • Attorney Docket Number
    PRINZ/TM4158
    Attorney Name
    Todd A. Sullivan
  • Owners
Mark Drawing Code
4
Mark Identification
ESCALATE
Case File Statements
  • GS0011: [ Biological and chemical reagents and preparations for laboratory and, scientific use; Biological and chemical preparations other than for medical or veterinary use for use in the determination of in-vitro properties of pharmaceutical substances, namely, Adsorption, Distribution, Metabolism, Excretion, or Toxicity (ADMET) properties of drug compounds and experimental drug candidates; reagent kits comprised of capture molecules namely serum albumin immobilized to beads of different composition, as well as buffer solutions for scientific or medical research purposes; assays for scientific or medical research purposes; assays and reagent kits comprised of capture molecules namely serum albumin immobilized to beads of different composition, as well as buffer solutions for use in binding of pharmaceutical development candidates to plasma proteins ]
  • GS0421: Custom design and development of biological and chemical reagents and biochemical assays; scientific research; scientific analysis services, namely in vitro analysis service for pharmaceutical research and development; scientific testing services in the field of pharmaceutical research and development; scientific laboratory services; [ scientific consultancy in the field of pharmaceutical research and development, research services in the field of pharmaceutical research and development; ] research services in the field of assaying binding of pharmaceutical development candidates to plasma proteins
Case File Event Statements
  • 6/23/2017 - 7 years ago
    3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 6/17/2017 - 7 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/21/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/27/2017 - 7 years ago
    4 - ASSIGNED TO LIE Type: ALIE
  • 7/31/2017 - 7 years ago
    5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 9/13/2017 - 7 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/13/2017 - 7 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/11/2017 - 7 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/12/2017 - 7 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/11/2018 - 7 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/31/2018 - 6 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/13/2017 - 7 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/13/2017 - 7 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/11/2017 - 7 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/20/2018 - 6 years ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/3/2024 - 3 months ago
    20 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 10/3/2024 - 3 months ago
    21 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P
  • 10/3/2024 - 3 months ago
    22 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85
  • 4/2/2024 - 9 months ago
    19 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 2/20/2018 - 6 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/8/2018 - 6 years ago
    17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/8/2023 - a year ago
    18 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1